UK firm OptiBiotix is looking to increase its APAC presence, with Food Standards and Safety Authority of India (FSSAI) approval the latest development in its expansion plans withits weight management product, SlimBiome.
Read about Blackmores' strategy overhaul in the wake of weak Q3 results, Bod Australia's continuing CBD innovations, Sirio Pharma's global R&D plans, and probiotics news from BLIS Technologies and Indian start-up MO's Superfoods.
Vitamin D deficiency has been documented to be highly prevalent among populations with liver issues, according to Thai researchers. Their new review of published studies outlines what we know so far about the vitamin’s role in liver health.
Tmall reveals China's top seven F&B trends, a Singapore-based sports nutrition retailer tells us about its plans to shake up the industry, and we bring you the latest on our upcoming Healthy Ageing APAC Summit and NutraIngredients-Asia Awards.
Supplementation of omega-3s EPA and DHA had a positive role in reducing muscle stiffness after exercise, according to new data published in the Journal of the International Society of Sports Nutrition.
NutraIngredients-Asia's annual awards are open for entries, and here are the final six judges who will assess the submissions from the best and brightest manufacturers, suppliers and researchers in the region.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.
Children diagnosed with autism, who took part in a faecal transplant procedure, found symptoms linked to the condition reduced by almost half, as the study also highlighted the long-term health benefits.